BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2775849)

  • 1. Aggregation of amphotericin B in the presence of gamma-cyclodextrin.
    Kajtár M; Vikmon M; Morlin E; Szejtli J
    Biopolymers; 1989 Sep; 28(9):1585-96. PubMed ID: 2775849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of amphotericin B with gamma-cyclodextrin.
    Vikmon M; Stadler-Szöke A; Szejtli J
    J Antibiot (Tokyo); 1985 Dec; 38(12):1822-4. PubMed ID: 4093341
    [No Abstract]   [Full Text] [Related]  

  • 3. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel formulation of solubilised amphotericin B designed for ophthalmic use.
    Serrano DR; Ruiz-Saldaña HK; Molero G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2012 Nov; 437(1-2):80-2. PubMed ID: 22890190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the solubility characteristics of griseofulvin with gamma-cyclodextrin.
    Kata M; Tüske B
    Pharmazie; 1988 Jan; 43(1):52-3. PubMed ID: 3375309
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Cyclodextrin:testosterone complex suitable for sublingual administration.
    Pitha J; Anaissie EJ; Uekama K
    J Pharm Sci; 1987 Oct; 76(10):788-90. PubMed ID: 3430342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular dichroism studies on intermolecular interactions of amphotericin B in ionic liquid-rich environments.
    Jameson LP; Dzyuba SV
    Chirality; 2013 Jul; 25(7):427-32. PubMed ID: 23695916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrins in drug carrier systems.
    Uekama K; Otagiri M
    Crit Rev Ther Drug Carrier Syst; 1987; 3(1):1-40. PubMed ID: 3542243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential use of cyclodextrins in parenteral formulations.
    Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
    J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Theoretical Analysis of Interaction Energies and Intermolecular Interactions between Amphotericin B and Potential Bioconjugates Used in the Modification of Nanocarriers for Drug Delivery.
    Cuellar J; Parada-Díaz L; Garza J; Mejía SM
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the percutaneous absorption of beclomethasone dipropionate by gamma-cyclodextrin complexation.
    Uekama K; Otagiri M; Sakai A; Irie T; Matsuo N; Matsuoka Y
    J Pharm Pharmacol; 1985 Aug; 37(8):532-5. PubMed ID: 2864411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexes of cyclodextrins with organic drug molecules.
    Uekama K
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S103-11. PubMed ID: 398896
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular insight into the inclusion of the dietary plant flavonol fisetin and its chromophore within a chemically modified γ-cyclodextrin: Multi-spectroscopic, molecular docking and solubility studies.
    Pahari B; Chakraborty S; Sengupta PK
    Food Chem; 2018 Sep; 260():221-230. PubMed ID: 29699666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclodextrins in isotachophoresis. VI. Cyclodextrins as leading electrolyte additives for the separation of bile acids.
    Snopek J; Smolková-Keulemansová E; Jelínek I; Dohnal J; Klinot J; Klinotová E
    J Chromatogr; 1988 Oct; 450(3):373-9. PubMed ID: 3241020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.